Grottoli, S.
Bianchi, A.
Bogazzi, F.
Bona, C.
Carlsson, M. O.
Colao, A.
Dassie, F.
Giampietro, A.
Gomez, R.
Granato, S.
Maffei, P.
Pivonello, R.
Prencipe, N.
Ragonese, M.
Urbani, C.
Cannavò, S.
Funding for this research was provided by:
Pfizer
Article History
Received: 24 November 2021
Accepted: 16 March 2022
First Online: 31 March 2022
Declarations
:
: Silvia Grottoli received research grants from Pfizer, Ipsen and Novartis and is a consultant for Pfizer. Martin Ove Carlsson, Roy Gomez and Simona Granato are employees and stockholders of Pfizer. Other authors have no conflicts of interest to declare.
: Prof. Nunzia Prencipe is among the Members of the Editorial Board of the Journal of Endocrinological Investigation.
: Ethical approval was obtained from the Comitato Etico dell’Università Cattolica del Sacro Cuore – Policlinico Universitario Agostino Gemelli di Roma, Rome, for the Italian coordinating center (i.e., Università Cattolica del Sacro Cuore, Rome, Italy) and from local Boards or Ethical Committees for all study centers.
: All patients provided written informed consent before enrollment in the study.